---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000803454.md"
description: "• Gilead Sciences leads in HIV treatments, facing competition from other drug companies.  $Gilead Sciences(GILD.US) • The stock market is experiencing a sell-off, particularly in AI-related stocks.  • CrowdStrike is expanding into AI Detection and Response, boosting its stock performance.  • Upcoming earnings reports from Google, Tesla, and Intel are critical for the AI sector.  • The semiconductor market is struggling, with chip stocks entering bear territory.  • Biotech stocks remain strong despite the downturn in AI stocks."
datetime: "2026-07-18T16:55:49.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000803454.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000803454.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000803454.md)
author: "[First Fellow](https://longbridge.com/en/profiles/27399941.md)"
generator: "portal-rs"
---

# • Gilead Sciences leads in HIV treatments, facing …


### Related Stocks

- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [TSLA.US](https://longbridge.com/en/quote/TSLA.US.md)
- [CRWD.US](https://longbridge.com/en/quote/CRWD.US.md)
- [GOOG.US](https://longbridge.com/en/quote/GOOG.US.md)
- [GOOGL.US](https://longbridge.com/en/quote/GOOGL.US.md)
- [GOOGN.US](https://longbridge.com/en/quote/GOOGN.US.md)
- [INTC.US](https://longbridge.com/en/quote/INTC.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**